Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
Fujian Green Pine
300132
5
Yili Chuanning Biotechnology
301301
US Stock MarketDetailed Quotes
GNLX Genelux
- 2.400
- -0.080-3.23%
Close May 14 16:00 ET
90.56MMarket Cap-2.76P/E (TTM)
2.573High2.400Low151.94KVolume2.500Open2.480Pre Close373.94KTurnover0.49%Turnover RatioLossP/E (Static)37.73MShares5.88552wk High3.03P/B74.18MFloat Cap1.60052wk Low--Dividend TTM30.91MShs Float40.980Historical High--Div YieldTTM6.96%Amplitude1.600Historical Low2.461Avg Price1Lot Size
Genelux Key Stats
Quarterly+Annual
YOY
| (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | (Q3)Sep 30, 2023 | (Q2)Jun 30, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow (Indirect Method) | ||||||||||
| Cash flow from continuing operating activities | -24.83%-5.44M | -4.70%-21.23M | 37.74%-4.3M | -71.22%-5.75M | -25.95%-6.82M | 5.14%-4.35M | -467.77%-20.28M | -355.20%-6.91M | -35.91%-3.36M | -125.00%-5.42M |
| Net income from continuing operations | 4.56%-7.49M | -5.56%-29.87M | -32.64%-8.98M | -20.99%-6.47M | -12.97%-6.58M | 24.26%-7.85M | -443.44%-28.3M | -93.62%-6.77M | -208.88%-5.35M | -106.42%-5.82M |
| Operating gains losses | ---- | ---- | ---- | ---- | ---- | ---- | --3.55M | --0 | --42K | --402K |
| Depreciation and amortization | -43.95%139K | -11.30%903K | 12.94%227K | -17.65%224K | -29.90%204K | -2.36%248K | 5.17%1.02M | -17.62%201K | 12.40%272K | 20.25%291K |
| Other non cash items | -89.59%103K | 5.35%1.67M | 93.98%322K | 54.42%227K | -68.30%136K | 16.77%989K | 2,937.50%1.59M | 50.91%166K | 200.00%147K | 262.50%429K |
| Change In working capital | -13.34%526K | 122.89%751K | 244.28%2.89M | -202.03%-1.01M | -74.77%-1.74M | 147.80%607K | -94.03%-3.28M | -226.77%-2M | 110.53%987K | -826.28%-995K |
| -Change in prepaid assets | 69.73%-171K | -25.67%359K | 211.07%927K | -248.50%-346K | 96.00%343K | -153.36%-565K | 387.50%483K | 7,550.00%298K | -33.43%233K | 119.64%175K |
| -Change in payables and accrued expense | -41.06%778K | 133.96%1.04M | 196.60%2.13M | -153.59%-493K | -88.22%-1.92M | 273.00%1.32M | -196.09%-3.07M | -239.81%-2.21M | 233.33%920K | -190.02%-1.02M |
| -Change in other current liabilities | 45.27%-81K | -24.47%-651K | -85.87%-171K | -1.20%-168K | -8.61%-164K | -29.82%-148K | -34.45%-523K | 13.21%-92K | -67.68%-166K | -45.19%-151K |
| -Change in other working capital | ---- | ---- | ---- | ---- | ---- | ---- | 96.07%-170K | --0 | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Operating cash flow | -24.83%-5.44M | -4.70%-21.23M | 37.74%-4.3M | -71.22%-5.75M | -25.95%-6.82M | 5.14%-4.35M | -467.77%-20.28M | -355.20%-6.91M | -35.91%-3.36M | -125.00%-5.42M |
| Investing cash flow | ||||||||||
| Cash flow from continuing investing activities | 307.51%3.51M | 44.78%-8.13M | 147.87%6.67M | 1,541.16%3.99M | -4,219.70%-17.11M | -1,451.38%-1.69M | -29,948.98%-14.72M | -13.94M | -739.39%-277K | -39,500.00%-396K |
| Net PPE purchase and sale | 0.00%-30K | 62.83%-381K | 60.49%-96K | 90.25%-27K | 42.42%-228K | 72.48%-30K | -1,991.84%-1.03M | ---243K | -739.39%-277K | -39,500.00%-396K |
| Net investment purchase and sale | 313.06%3.54M | 43.43%-7.75M | 149.42%6.77M | --4.02M | ---16.88M | ---1.66M | ---13.7M | ---13.7M | --0 | --0 |
| Cash from discontinued investing activities | ||||||||||
| Investing cash flow | 307.51%3.51M | 44.78%-8.13M | 147.87%6.67M | 1,541.16%3.99M | -4,219.70%-17.11M | -1,451.38%-1.69M | -29,948.98%-14.72M | ---13.94M | -739.39%-277K | -39,500.00%-396K |
| Financing cash flow | ||||||||||
| Cash flow from continuing financing activities | 1,290.55%9.57M | -35.24%28.51M | -77.31%91K | 0 | 22.60%27.73M | -95.30%688K | 9,309.21%44.02M | -26.42%401K | 2,034.04%6.36M | 4,109.93%22.62M |
| Net issuance payments of debt | ---- | --0 | --0 | --0 | --0 | --0 | -77.84%215K | --0 | ---25K | ---200K |
| Net common stock issuance | --9.55M | -29.83%27.82M | --91K | -98.60%49K | 27.89%27.68M | --0 | --39.65M | --0 | --3.5M | --21.64M |
| Proceeds from stock option exercised by employees | -97.97%14K | -84.58%688K | --0 | -101.70%-49K | -95.83%49K | --688K | 3,619.17%4.46M | --401K | 2,306.67%2.89M | --1.17M |
| Net other financing activities | ---- | ---- | ---- | ---- | ---- | ---- | 80.68%-303K | --0 | --0 | --0 |
| Cash from discontinued financing activities | ||||||||||
| Financing cash flow | 1,290.55%9.57M | -35.24%28.51M | -77.31%91K | --0 | 22.60%27.73M | -95.30%688K | 9,309.21%44.02M | -26.42%401K | 2,034.04%6.36M | 4,109.93%22.62M |
| Net cash flow | ||||||||||
| Beginning cash position | -9.06%8.57M | 2,272.29%9.42M | -79.57%6.1M | -71.05%7.86M | -60.72%4.06M | 2,272.29%9.42M | -91.17%397K | 2,080.22%29.87M | 545.88%27.14M | 44.08%10.34M |
| Current changes in cash | 242.64%7.64M | -109.46%-853K | 112.04%2.46M | -164.35%-1.76M | -77.40%3.8M | -153.89%-5.36M | 320.13%9.02M | -2,001.85%-20.45M | 196.36%2.73M | 665.15%16.8M |
| End cash Position | 299.06%16.21M | -9.06%8.57M | -9.06%8.57M | -79.57%6.1M | -71.05%7.86M | -60.72%4.06M | 2,272.29%9.42M | 2,272.29%9.42M | 2,080.22%29.87M | 545.88%27.14M |
| Free cash flow | -24.66%-5.47M | -1.45%-21.61M | 38.52%-4.4M | -58.92%-5.78M | -21.29%-7.05M | 6.70%-4.38M | -488.40%-21.3M | -371.21%-7.15M | -45.19%-3.63M | -141.34%-5.81M |
| Currency Unit | USD | USD | USD | USD | USD | USD | USD | USD | USD | USD |
| Audit Opinions | -- | Unqualified Opinion with Explanatory Notes | -- | -- | -- | -- | -- | -- | -- | -- |
Market Insights
Discussing
Trade war escalates: What’s next for Chinese stocks?
🎙️Discussion 1. China-EU EV negotiations kick off recently. How do you think the negotiations will impact the performance of related stocks
Moo Earnings
Feb 17 19:21
Alibaba Q4 FY2024 Earnings Preview: Predict & Win Big! 🚀
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries
Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.
Unlock Now
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.
Unlock Now
